-
1
-
-
80053071543
-
Androgen receptor rediscovered: The new biology and targeting the androgen receptor therapeutically
-
Ryan CJ, Tindall DJ. Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically. J Clin Oncol. 2011;29(27):3651-3658.
-
(2011)
J Clin Oncol
, vol.29
, Issue.27
, pp. 3651-3658
-
-
Ryan, C.J.1
Tindall, D.J.2
-
2
-
-
77956793432
-
Molecular genetics of prostate cancer: New prospects for old challenges
-
Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010;24(18):1967-2000.
-
(2010)
Genes Dev
, vol.24
, Issue.18
, pp. 1967-2000
-
-
Shen, M.M.1
Abate-Shen, C.2
-
3
-
-
70350109641
-
ETS gene fusions in prostate cancer
-
Clark JP, Cooper CS. ETS gene fusions in prostate cancer. Nat Rev Urol. 2009;6(8):429-439.
-
(2009)
Nat Rev Urol
, vol.6
, Issue.8
, pp. 429-439
-
-
Clark, J.P.1
Cooper, C.S.2
-
4
-
-
79959466181
-
Genomic and biochemical insights into the specificity of ETS transcription factors
-
Hollenhorst PC, McIntosh LP, Graves BJ. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem. 2011;80:437-471.
-
(2011)
Annu Rev Biochem
, vol.80
, pp. 437-471
-
-
Hollenhorst, P.C.1
McIntosh, L.P.2
Graves, B.J.3
-
5
-
-
84859038513
-
ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
-
Oh S, Shin S, Janknecht R. ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta. 2012;1826(1):1-12.
-
(2012)
Biochim Biophys Acta
, vol.1826
, Issue.1
, pp. 1-12
-
-
Oh, S.1
Shin, S.2
Janknecht, R.3
-
6
-
-
70350228463
-
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81
-
Shin S, et al. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res. 2009;69(20):8102-8110.
-
(2009)
Cancer Res
, vol.69
, Issue.20
, pp. 8102-8110
-
-
Shin, S.1
-
7
-
-
84875333536
-
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
-
Baena E, et al. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes Dev. 2013;27(6):683-698.
-
(2013)
Genes Dev
, vol.27
, Issue.6
, pp. 683-698
-
-
Baena, E.1
-
8
-
-
84863621527
-
Cancer epigenetics: From mechanism to therapy
-
Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012; 150(1):12-27.
-
(2012)
Cell
, vol.150
, Issue.1
, pp. 12-27
-
-
Dawson, M.A.1
Kouzarides, T.2
-
9
-
-
21744457108
-
Global histone modification patterns predict risk of prostate cancer recurrence
-
Seligson DB, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435(7046):1262-1266.
-
(2005)
Nature
, vol.435
, Issue.7046
, pp. 1262-1266
-
-
Seligson, D.B.1
-
10
-
-
72849148472
-
Global levels of histone modifications predict prostate cancer recurrence
-
Ellinger J, et al. Global levels of histone modifications predict prostate cancer recurrence. Prostate. 2010;70(1):61-69.
-
(2010)
Prostate
, vol.70
, Issue.1
, pp. 61-69
-
-
Ellinger, J.1
-
11
-
-
77953995002
-
Covalent histone modifications - Miswritten, misinterpreted and mis-erased in human cancers
-
Chi P, Allis CD, Wang GG. Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer. 2010;10(7):457-469.
-
(2010)
Nat Rev Cancer
, vol.10
, Issue.7
, pp. 457-469
-
-
Chi, P.1
Allis, C.D.2
Wang, G.G.3
-
12
-
-
84860215207
-
Molecular mechanisms and potential functions of histone demethylases
-
Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol. 2012;13(5):297-311.
-
(2012)
Nat Rev Mol Cell Biol
, vol.13
, Issue.5
, pp. 297-311
-
-
Kooistra, S.M.1
Helin, K.2
-
13
-
-
84877861510
-
KDM4/JMJD2 histone demethylases: Epigenetic regulators in cancer cells
-
Berry WL, Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 2013;73(10):2936-2942.
-
(2013)
Cancer Res
, vol.73
, Issue.10
, pp. 2936-2942
-
-
Berry, W.L.1
Janknecht, R.2
-
14
-
-
0035959808
-
HER2/Neumediated activation of the ETS transcription factor ER81 and its target gene MMP-1
-
Bosc DG, Goueli BS, Janknecht R. HER2/Neumediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene. 2001;20(43):6215-6224.
-
(2001)
Oncogene
, vol.20
, Issue.43
, pp. 6215-6224
-
-
Bosc, D.G.1
Goueli, B.S.2
Janknecht, R.3
-
15
-
-
33646124469
-
Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases
-
Whetstine JR, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell. 2006;125(3):467-481.
-
(2006)
Cell
, vol.125
, Issue.3
, pp. 467-481
-
-
Whetstine, J.R.1
-
16
-
-
33745847680
-
The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36
-
Klose RJ, et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature. 2006;442(7100):312-316.
-
(2006)
Nature
, vol.442
, Issue.7100
, pp. 312-316
-
-
Klose, R.J.1
-
17
-
-
33746332412
-
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
-
Cloos PA, et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature. 2006;442(7100):307-311.
-
(2006)
Nature
, vol.442
, Issue.7100
, pp. 307-311
-
-
Cloos, P.A.1
-
18
-
-
9144251970
-
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
-
Lapointe J, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A. 2004;101(3):811-816.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, Issue.3
, pp. 811-816
-
-
Lapointe, J.1
-
19
-
-
34547411003
-
ETV1 is a novel androgen receptorregulated gene that mediates prostate cancer cell invasion
-
Cai C, et al. ETV1 is a novel androgen receptorregulated gene that mediates prostate cancer cell invasion. Mol Endocrinol. 2007;21(8):1835-1846.
-
(2007)
Mol Endocrinol
, vol.21
, Issue.8
, pp. 1835-1846
-
-
Cai, C.1
-
20
-
-
34547642493
-
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
-
Tomlins SA, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007;448(7153):595-599.
-
(2007)
Nature
, vol.448
, Issue.7153
, pp. 595-599
-
-
Tomlins, S.A.1
-
21
-
-
0034520311
-
A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo
-
Zhang J, Thomas TZ, Kasper S, Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology. 2000;141(12):4698-4710.
-
(2000)
Endocrinology
, vol.141
, Issue.12
, pp. 4698-4710
-
-
Zhang, J.1
Thomas, T.Z.2
Kasper, S.3
Matusik, R.J.4
-
22
-
-
0036966275
-
Prostatic intraepithelial neoplasia in genetically engineered mice
-
Park JH, et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol. 2002;161(2):727-735.
-
(2002)
Am J Pathol
, vol.161
, Issue.2
, pp. 727-735
-
-
Park, J.H.1
-
23
-
-
0031870959
-
Pten is essential for embryonic development and tumour suppression
-
Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998;19(4):348-355.
-
(1998)
Nat Genet
, vol.19
, Issue.4
, pp. 348-355
-
-
Di Cristofano, A.1
Pesce, B.2
Cordon-Cardo, C.3
Pandolfi, P.P.4
-
24
-
-
4243110417
-
Pten dose dictates cancer progression in the prostate
-
Trotman LC, et al. Pten dose dictates cancer progression in the prostate. PLoS Biol. 2003;1(3):E59.
-
(2003)
PLoS Biol
, vol.1
, Issue.3
, pp. E59
-
-
Trotman, L.C.1
-
25
-
-
84859569827
-
Targeting angiogenesis for the treatment of prostate cancer
-
Antonarakis ES, Carducci MA. Targeting angiogenesis for the treatment of prostate cancer. Expert Opin Ther Targets. 2012;16(4):365-376.
-
(2012)
Expert Opin Ther Targets
, vol.16
, Issue.4
, pp. 365-376
-
-
Antonarakis, E.S.1
Carducci, M.A.2
-
26
-
-
57049114832
-
The genetics of the p53 pathway, apoptosis and cancer therapy
-
Vazquez A, Bond EE, Levine AJ, Bond GL. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov. 2008;7(12):979-987.
-
(2008)
Nat Rev Drug Discov
, vol.7
, Issue.12
, pp. 979-987
-
-
Vazquez, A.1
Bond, E.E.2
Levine, A.J.3
Bond, G.L.4
-
28
-
-
84874257648
-
The Hippo pathway: Regulators and regulations
-
Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27(4):355-371.
-
(2013)
Genes Dev
, vol.27
, Issue.4
, pp. 355-371
-
-
Yu, F.X.1
Guan, K.L.2
-
29
-
-
0042591506
-
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression
-
Xu LL, et al. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res. 2003;63(15):4299-4304.
-
(2003)
Cancer Res
, vol.63
, Issue.15
, pp. 4299-4304
-
-
Xu, L.L.1
-
30
-
-
57649198310
-
A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells
-
Li H, et al. A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J Biol Chem. 2008;283(43):28988-28995.
-
(2008)
J Biol Chem
, vol.283
, Issue.43
, pp. 28988-28995
-
-
Li, H.1
-
31
-
-
84872861372
-
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells
-
Shin S, Oh S, An S, Janknecht R. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncol Rep. 2013;29(1):306-314.
-
(2013)
Oncol Rep
, vol.29
, Issue.1
, pp. 306-314
-
-
Shin, S.1
Oh, S.2
An, S.3
Janknecht, R.4
-
32
-
-
67649205713
-
A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide
-
Wren JD. A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide. Bioinformatics. 2009;25(13):1694-1701.
-
(2009)
Bioinformatics
, vol.25
, Issue.13
, pp. 1694-1701
-
-
Wren, J.D.1
-
33
-
-
0029926301
-
Analysis of the ERK-stimulated ETS transcription factor ER81
-
Janknecht R. Analysis of the ERK-stimulated ETS transcription factor ER81. Mol Cell Biol. 1996;16(4):1550-1556.
-
(1996)
Mol Cell Biol
, vol.16
, Issue.4
, pp. 1550-1556
-
-
Janknecht, R.1
-
34
-
-
0242497921
-
HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81
-
Dowdy SC, Mariani A, Janknecht R. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol Chem. 2003;278(45):44377-44384.
-
(2003)
J Biol Chem
, vol.278
, Issue.45
, pp. 44377-44384
-
-
Dowdy, S.C.1
Mariani, A.2
Janknecht, R.3
-
35
-
-
84925381625
-
The Hippo pathway effector YAP regulates motility, invasion, and castrationresistant growth of prostate cancer cells
-
Zhang L, et al. The Hippo pathway effector YAP regulates motility, invasion, and castrationresistant growth of prostate cancer cells. Mol Cell Biol. 2015;35(8):1350-1362.
-
(2015)
Mol Cell Biol
, vol.35
, Issue.8
, pp. 1350-1362
-
-
Zhang, L.1
-
36
-
-
84862605178
-
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
-
Liu-Chittenden Y, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26(12):1300-1305.
-
(2012)
Genes Dev
, vol.26
, Issue.12
, pp. 1300-1305
-
-
Liu-Chittenden, Y.1
-
37
-
-
84856120332
-
Understanding the language of Lys36 methylation at histone H3
-
Wagner EJ, Carpenter PB. Understanding the language of Lys36 methylation at histone H3. Nat Rev Mol Cell Biol. 2012;13(2):115-126.
-
(2012)
Nat Rev Mol Cell Biol
, vol.13
, Issue.2
, pp. 115-126
-
-
Wagner, E.J.1
Carpenter, P.B.2
-
38
-
-
23344436787
-
Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein
-
Gray SG, et al. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem. 2005;280(31):28507-28518.
-
(2005)
J Biol Chem
, vol.280
, Issue.31
, pp. 28507-28518
-
-
Gray, S.G.1
-
39
-
-
22544465244
-
JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2)
-
Zhang D, Yoon HG, Wong J. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol Cell Biol. 2005;25(15):6404-6414.
-
(2005)
Mol Cell Biol
, vol.25
, Issue.15
, pp. 6404-6414
-
-
Zhang, D.1
Yoon, H.G.2
Wong, J.3
-
40
-
-
84859895529
-
RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites
-
Mallette FA, et al. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites. EMBO J. 2012;31(8):1865-1878.
-
(2012)
EMBO J
, vol.31
, Issue.8
, pp. 1865-1878
-
-
Mallette, F.A.1
-
41
-
-
84881154753
-
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors
-
Black JC, et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell. 2013;154(3):541-555.
-
(2013)
Cell
, vol.154
, Issue.3
, pp. 541-555
-
-
Black, J.C.1
-
42
-
-
84924415145
-
Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis
-
Van Rechem C, et al. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis. Cancer Discov. 2015;5(3):255-263.
-
(2015)
Cancer Discov
, vol.5
, Issue.3
, pp. 255-263
-
-
Van Rechem, C.1
-
43
-
-
34250168304
-
Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D
-
Shin S, Janknecht R. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun. 2007;359(3):742-746.
-
(2007)
Biochem Biophys Res Commun
, vol.359
, Issue.3
, pp. 742-746
-
-
Shin, S.1
Janknecht, R.2
-
44
-
-
84882285291
-
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
-
Chen Y, et al. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat Med. 2013;19(8):1023-1029.
-
(2013)
Nat Med
, vol.19
, Issue.8
, pp. 1023-1029
-
-
Chen, Y.1
-
45
-
-
84920363474
-
Only three driver gene mutations are required for the development of lung and colorectal cancers
-
Tomasetti C, Marchionni L, Nowak MA, Parmigiani G, Vogelstein B. Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci U S A. 2015;112(1):118-123.
-
(2015)
Proc Natl Acad Sci U S A
, vol.112
, Issue.1
, pp. 118-123
-
-
Tomasetti, C.1
Marchionni, L.2
Nowak, M.A.3
Parmigiani, G.4
Vogelstein, B.5
-
46
-
-
84055211870
-
Lysine demethylases inhibitors
-
Suzuki T, Miyata N. Lysine demethylases inhibitors. J Med Chem. 2011;54(24):8236-8250.
-
(2011)
J Med Chem
, vol.54
, Issue.24
, pp. 8236-8250
-
-
Suzuki, T.1
Miyata, N.2
-
47
-
-
84903155987
-
Histone lysine demethylase (KDM) subfamily 4: Structures, functions and therapeutic potential
-
Labbe RM, Holowatyj A, Yang ZQ. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am J Transl Res. 2013;6(1):1-15.
-
(2013)
Am J Transl Res
, vol.6
, Issue.1
, pp. 1-15
-
-
Labbe, R.M.1
Holowatyj, A.2
Yang, Z.Q.3
-
48
-
-
84889595831
-
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
-
Wang L, et al. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth. Nat Commun. 2013;4:2035.
-
(2013)
Nat Commun
, vol.4
, pp. 2035
-
-
Wang, L.1
-
49
-
-
35948961118
-
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
-
Zhao B, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747-2761.
-
(2007)
Genes Dev
, vol.21
, Issue.21
, pp. 2747-2761
-
-
Zhao, B.1
-
50
-
-
84930591340
-
ERG activates the YAP1 transcriptional program and induces the development of age-related prostate tumors
-
Nguyen LT, et al. ERG activates the YAP1 transcriptional program and induces the development of age-related prostate tumors. Cancer Cell. 2015;27(6):797-808.
-
(2015)
Cancer Cell
, vol.27
, Issue.6
, pp. 797-808
-
-
Nguyen, L.T.1
-
51
-
-
84923183206
-
The emerging roles of YAP and TAZ in cancer
-
Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73-79.
-
(2015)
Nat Rev Cancer
, vol.15
, Issue.2
, pp. 73-79
-
-
Moroishi, T.1
Hansen, C.G.2
Guan, K.L.3
-
52
-
-
84893576085
-
A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer
-
Jiao S, et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014;25(2):166-180.
-
(2014)
Cancer Cell
, vol.25
, Issue.2
, pp. 166-180
-
-
Jiao, S.1
-
53
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
Tomlins SA, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310(5748):644-648.
-
(2005)
Science
, vol.310
, Issue.5748
, pp. 644-648
-
-
Tomlins, S.A.1
-
54
-
-
84930573987
-
The TGF-β signaling regulator PMEPA1 suppresses prostate cancer metastases to bone
-
Fournier PGJ, et al. The TGF-β signaling regulator PMEPA1 suppresses prostate cancer metastases to bone. Cancer Cell. 2015;27(6):809-821.
-
(2015)
Cancer Cell
, vol.27
, Issue.6
, pp. 809-821
-
-
Fournier, P.G.J.1
-
55
-
-
73649085521
-
TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling
-
Watanabe Y, et al. TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. Mol Cell. 2010;37(1):123-134.
-
(2010)
Mol Cell
, vol.37
, Issue.1
, pp. 123-134
-
-
Watanabe, Y.1
-
56
-
-
0036899998
-
High expression of the Met receptor in prostate cancer metastasis to bone
-
Knudsen BS, et al. High expression of the Met receptor in prostate cancer metastasis to bone. Urology. 2002;60(6):1113-1117.
-
(2002)
Urology
, vol.60
, Issue.6
, pp. 1113-1117
-
-
Knudsen, B.S.1
-
57
-
-
84860340496
-
Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2
-
Tomic TT, Gustavsson H, Wang W, Jennbacken K, Welen K, Damber JE. Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2. Prostate. 2012;72(7):705-712.
-
(2012)
Prostate
, vol.72
, Issue.7
, pp. 705-712
-
-
Tomic, T.T.1
Gustavsson, H.2
Wang, W.3
Jennbacken, K.4
Welen, K.5
Damber, J.E.6
-
58
-
-
84863115795
-
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
-
Kim TD, Shin S, Berry WL, Oh S, Janknecht R. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J Cell Biochem. 2012;113(4):1368-1376.
-
(2012)
J Cell Biochem
, vol.113
, Issue.4
, pp. 1368-1376
-
-
Kim, T.D.1
Shin, S.2
Berry, W.L.3
Oh, S.4
Janknecht, R.5
-
59
-
-
84867808958
-
Oncogenic features of the JMJD2A histone demethylase in breast cancer
-
Berry WL, Shin S, Lightfoot SA, Janknecht R. Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int J Oncol. 2012;41(5):1701-1706.
-
(2012)
Int J Oncol
, vol.41
, Issue.5
, pp. 1701-1706
-
-
Berry, W.L.1
Shin, S.2
Lightfoot, S.A.3
Janknecht, R.4
-
60
-
-
84870463217
-
JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5
-
Mallette FA, Richard S. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep. 2012;2(5):1233-1243.
-
(2012)
Cell Rep
, vol.2
, Issue.5
, pp. 1233-1243
-
-
Mallette, F.A.1
Richard, S.2
-
61
-
-
0037421959
-
Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1)
-
Janknecht R. Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1). Oncogene. 2003;22(5):746-755.
-
(2003)
Oncogene
, vol.22
, Issue.5
, pp. 746-755
-
-
Janknecht, R.1
-
62
-
-
0033830524
-
Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300
-
Papoutsopoulou S, Janknecht R. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol Cell Biol. 2000;20(19):7300-7310.
-
(2000)
Mol Cell Biol
, vol.20
, Issue.19
, pp. 7300-7310
-
-
Papoutsopoulou, S.1
Janknecht, R.2
-
63
-
-
0042971584
-
Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu
-
Goel A, Janknecht R. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol. 2003;23(17):6243-6254.
-
(2003)
Mol Cell Biol
, vol.23
, Issue.17
, pp. 6243-6254
-
-
Goel, A.1
Janknecht, R.2
-
64
-
-
84894451091
-
Stimulation of beta-catenin and colon cancer cell growth by the KDM4B histone demethylase
-
Berry WL, Kim TD, Janknecht R. Stimulation of beta-catenin and colon cancer cell growth by the KDM4B histone demethylase. Int J Oncol. 2014;44(4):1341-1348.
-
(2014)
Int J Oncol
, vol.44
, Issue.4
, pp. 1341-1348
-
-
Berry, W.L.1
Kim, T.D.2
Janknecht, R.3
-
65
-
-
0024328068
-
Eukaryotic expression vectors for the analysis of mutant proteins
-
Matthias P, Muller MM, Schreiber E, Rusconi S, Schaffner W. Eukaryotic expression vectors for the analysis of mutant proteins. Nucleic Acids Res. 1989;17(15):6418.
-
(1989)
Nucleic Acids Res
, vol.17
, Issue.15
, pp. 6418
-
-
Matthias, P.1
Muller, M.M.2
Schreiber, E.3
Rusconi, S.4
Schaffner, W.5
-
66
-
-
0037044832
-
Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A
-
Wu J, Janknecht R. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J Biol Chem. 2002;277(45):42669-42679.
-
(2002)
J Biol Chem
, vol.277
, Issue.45
, pp. 42669-42679
-
-
Wu, J.1
Janknecht, R.2
-
67
-
-
33847246805
-
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
-
Rhodes DR, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166-180.
-
(2007)
Neoplasia
, vol.9
, Issue.2
, pp. 166-180
-
-
Rhodes, D.R.1
-
68
-
-
84882728530
-
14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer
-
Oh S, Shin S, Lightfoot SA, Janknecht R. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer. Cancer Res. 2013;73(16):5110-5119.
-
(2013)
Cancer Res
, vol.73
, Issue.16
, pp. 5110-5119
-
-
Oh, S.1
Shin, S.2
Lightfoot, S.A.3
Janknecht, R.4
-
69
-
-
84859725611
-
Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D
-
Kim TD, Oh S, Shin S, Janknecht R. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D. PLoS One. 2012;7(4):e34618.
-
(2012)
PLoS One
, vol.7
, Issue.4
, pp. e34618
-
-
Kim, T.D.1
Oh, S.2
Shin, S.3
Janknecht, R.4
-
70
-
-
13044250465
-
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
-
Podsypanina K, et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999;96(4):1563-1568.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, Issue.4
, pp. 1563-1568
-
-
Podsypanina, K.1
-
71
-
-
84863611733
-
Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis
-
DiTacchio L, Bowles J, Shin S, Lim DS, Koopman P, Janknecht R. Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis. J Biol Chem. 2012;287(28):23657-23666.
-
(2012)
J Biol Chem
, vol.287
, Issue.28
, pp. 23657-23666
-
-
DiTacchio, L.1
Bowles, J.2
Shin, S.3
Lim, D.S.4
Koopman, P.5
Janknecht, R.6
-
72
-
-
2442607847
-
Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu
-
Goel A, Janknecht R. Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J Biol Chem. 2004;279(15):14909-14916.
-
(2004)
J Biol Chem
, vol.279
, Issue.15
, pp. 14909-14916
-
-
Goel, A.1
Janknecht, R.2
-
73
-
-
0345549479
-
Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor
-
Goueli BS, Janknecht R. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene. 2003;22(39):8042-8047.
-
(2003)
Oncogene
, vol.22
, Issue.39
, pp. 8042-8047
-
-
Goueli, B.S.1
Janknecht, R.2
|